Nymox Pharmaceutical Corp (NYMXF)

[dustinsilvers1]

And as I said earlier. NYMX is a start-up company whose conference call was weak,unprofessional and stated untrue or half-truths to their shareholders. Now this is not to say longer term with the prostate commercialization this company could show very good prospects however in the conference call the CEO stated that NYMX has NO DEBT. Today they reported:
Nymox Pharmaceutical Corp. on Monday reported a loss of $2.8 million in its first quarter. On a per-share basis, the Nassau, Bahamas-based company said it had a loss of 6 cents. The biopharmaceutical company posted revenue of $78,400 in the period.
So you define to me what NO DEBT means. They had a loss of $2.8 million and only revenues of $78,400. In my world this is debt.